ZA988096B - Ureido and thioureido derivatives of 40-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents. - Google Patents

Ureido and thioureido derivatives of 40-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents.

Info

Publication number
ZA988096B
ZA988096B ZA9808096A ZA988096A ZA988096B ZA 988096 B ZA988096 B ZA 988096B ZA 9808096 A ZA9808096 A ZA 9808096A ZA 988096 A ZA988096 A ZA 988096A ZA 988096 B ZA988096 B ZA 988096B
Authority
ZA
South Africa
Prior art keywords
amino
thiophenones
furanones
ureido
antitumor agents
Prior art date
Application number
ZA9808096A
Other languages
English (en)
Inventor
Ernesto Menta
Nicoletta Pescalli
Marco Conti
Gerd Zimmermann
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA988096B publication Critical patent/ZA988096B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9808096A 1997-09-05 1998-09-04 Ureido and thioureido derivatives of 40-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents. ZA988096B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115391 1997-09-05

Publications (1)

Publication Number Publication Date
ZA988096B true ZA988096B (en) 2000-03-22

Family

ID=8227318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9808096A ZA988096B (en) 1997-09-05 1998-09-04 Ureido and thioureido derivatives of 40-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents.

Country Status (16)

Country Link
US (2) US6333346B1 (xx)
EP (1) EP1009747A1 (xx)
JP (1) JP2001515894A (xx)
KR (1) KR20010023549A (xx)
CN (1) CN1278256A (xx)
AR (1) AR014908A1 (xx)
AU (1) AU748490B2 (xx)
BR (1) BR9812629A (xx)
CA (1) CA2302284A1 (xx)
CO (1) CO4970714A1 (xx)
HR (1) HRP980480A2 (xx)
MA (1) MA24668A1 (xx)
PE (1) PE107599A1 (xx)
TR (1) TR200000589T2 (xx)
WO (1) WO1999012917A1 (xx)
ZA (1) ZA988096B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1309593B1 (it) * 1999-03-05 2002-01-24 Novuspharma Spa Composti eterociclici ad attivita' antitumorale.
KR20010094519A (ko) * 2000-03-31 2001-11-01 서경배 2,2,4,5-사중 치환된 3(2h)-퓨라논 유도체의 제조 방법
GB9928696D0 (en) 1999-12-03 2000-02-02 Swan Thomas & Co Ltd Optical devices and methods of manufacture thereof
IT1315267B1 (it) 1999-12-23 2003-02-03 Novuspharma Spa Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
US20060211759A1 (en) * 2001-07-26 2006-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Bis-heterocyclic compounds with antitumour and chemosensitising activity
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
EP2386551A1 (en) * 2002-07-09 2011-11-16 Fasgen Inc. Novel compounds, pharmaceutical compositions containing same, and methods of use for same
KR20040018295A (ko) * 2002-08-22 2004-03-03 임철부 항암 활성을 갖는 티오우레이도 세라마이드 유도체 및 이화합물을 함유하는 약학적 조성물
KR100555655B1 (ko) * 2002-11-20 2006-03-03 임철부 항암 활성을 갖는 우레이도 또는 티오우레이도 유도체 및이 화합물을 함유하는 약학조성물
CN1301253C (zh) * 2003-07-31 2007-02-21 中国人民解放军军事医学科学院毒物药物研究所 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途
CN101161645B (zh) * 2007-11-27 2010-06-23 南京大学 尿素类衍生物及其制备方法与用途
CN101560175B (zh) * 2009-05-08 2012-10-10 南京大学 一类硫脲类衍生物及其制备方法与用途
CN106800544B (zh) * 2017-01-19 2019-09-06 华南师范大学 3-卤-4-联苯胺基-2(5h)-呋喃酮类化合物及其在制备抗肿瘤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27894E (en) * 1972-05-15 1974-01-22 Hydroxy-j-(j-phenylureido)crotonic acid, gamma lactone compounds
AR206143A1 (es) * 1974-04-17 1976-06-30 Du Pont Procedimiento para la preparacion de compuestos de 1 - t - alquil - 3 - (2,5 - dihidro - 5 - oxo - 3 - furil) ureas
SE7702004L (sv) * 1976-03-24 1977-09-25 Du Pont Antihypertensiva furylkarbamider
JPS63174983A (ja) * 1987-01-16 1988-07-19 Sumitomo Chem Co Ltd アミノブテノリド誘導体、その製造法およびそれを有効成分とする除草剤

Also Published As

Publication number Publication date
CN1278256A (zh) 2000-12-27
BR9812629A (pt) 2000-08-22
TR200000589T2 (tr) 2000-07-21
AR014908A1 (es) 2001-04-11
US6333346B1 (en) 2001-12-25
CO4970714A1 (es) 2000-11-07
EP1009747A1 (en) 2000-06-21
HRP980480A2 (en) 1999-06-30
KR20010023549A (ko) 2001-03-26
AU9535098A (en) 1999-03-29
JP2001515894A (ja) 2001-09-25
WO1999012917A1 (en) 1999-03-18
US20020058694A1 (en) 2002-05-16
PE107599A1 (es) 1999-11-03
AU748490B2 (en) 2002-06-06
MA24668A1 (fr) 1999-07-01
CA2302284A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
HUP9601559A2 (en) Heterocyclic ring-fused pyrimidine derivatives, pharmaceutical compositions containing the same and intermediates
IL126381A (en) Heterocyclic azahexane derivatives and antiviral compositions containing them
PL329177A1 (en) Derivatives of azahexane ehxibiting antiviral activity
AU4624993A (en) Cyclic urea derivatives
ZA988096B (en) Ureido and thioureido derivatives of 40-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents.
HUP0002194A3 (en) Compositions containing prostaglandine derivatives and methods for reducing ocular hypertension
HK1007880A1 (en) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
GB2299024B (en) Underarm compostions
AU4085497A (en) 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5H) -furanones and methods of use therefor
PL337645A1 (en) Novel amidine derivatives and their application as thrombosin inhibitors
HUP9901433A3 (en) Hydrophobic taxane derivatives and medicaments comprising them
PL316562A1 (en) Mining crib and its beam
PL310806A1 (en) Amidine derivatives containing heterocyclic groups, their production and application of such derivatives
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
IL134193A0 (en) O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
GB9511355D0 (en) Urea derivatives
ZA949150B (en) Pyrone derivatives as protease inhibitors and antiviral agents.
HUT68220A (en) Urea derivatives containing heterocyclic ring and pharmaceutical compositions containing them
IL120669A0 (en) Benzylamine derivatives and pharmaceutical compositions containing them
ZA981665B (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
NZ318390A (en) R(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl (or hydroxymethyl) pyrimidine and medicaments
GB9613455D0 (en) Analogues or derivatives of quercetin
NZ313790A (en) Nucleoside derivatives, being esters of 1-beta-d-arabinofuranosylcytosine, in treating tumours and lymphomas
IL91773A0 (en) 2'haloethylidene,2'-ethenylidene and 2'-ethynyl adenosine derivatives
GB2297646B (en) Laser arrangement and method of operating said laser arrangement